A prospective, randomized study to assess the tolerance and efficacy of intramuscular and subcutaneous administration of recombinant follicle-stimulating hormone (Puregon)

This publication has 13 references indexed in Scilit:

• Recombinat hormones: Molecular biology and biochemistry of human recombinant follicle stimulating hormone (Puregon^®)
  Molecular Human Reproduction, 1996
• Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization.
  Fertility and Sterility, 1995
• Human gonadotrophin preparations May cause allergic reaction
  BMJ, 1994
• Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects
  Fertility and Sterility, 1994
• New gonadotropins for old?
  The Lancet, 1992
• Comparativein Vitroandin VivoStudies on the Biological Characteristics of Recombinant Human Follicle-Stimulating Hormone
  Endocrinology, 1991
• Isolation and structure determination of the intact sialylated N‐linked carbohydrate chains of recombinant human follitropin expressed in Chinese hamster ovary cells
  European Journal of Biochemistry, 1990
• Good Clinical Practice for Trials on Medicinal Products in the European Community: CPMP Working Party on Efficacy of Medicinal Products
  Basic & Clinical Pharmacology & Toxicology, 1990
• Clinical experience in the induction of ovulation and pregnancy with pulsatile subcutaneous administration of human menopausal gonadotropin: a low incidence of multiple pregnancy
  Fertility and Sterility, 1989
• Risk factors and prognostic variables in the ovarian hyperstimulation syndrome
  American Journal of Obstetrics and Gynecology, 1988